Trial Profile
Gemcitabine plus nab-paclitaxel versus folfirinox as neoadjuvant treatment in patients with potentially resectable pancreatic carcinoma. NeoPAN Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2014
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Fluorouracil; Gemcitabine; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms NeoPAN
- 14 Jul 2014 New trial record